Home/Insights/Top Healthcare Market Research Companies in Ireland

Healthcare & Pharma Research — 2026 Expert Guide

Top Healthcare Market Research Companies in Ireland (2026 Guide)

An expert guide to the leading healthcare and pharmaceutical market research companies operating in Ireland for 2026. This guide profiles 7 firms with demonstrated capability in REC-compliant HCP surveys, KOL mapping across Irish academic medical centres, HSE and NCPE payer research, IPHA framework agreement awareness, HPRA regulatory alignment, and HEOR evidence generation — to help you select the right research partner for the Irish healthcare market.

Published June 2026 · By BioNixus Research Team · 15 min read

EU Pharma Hub

Global manufacturing base

HSE

Single national payer

HPRA + NCPE

Key regulators

Firms profiled

Top healthcare market research companies in Ireland 2026

BioNixus ranks #1 among healthcare market research companies in Ireland, specialising in REC-compliant HCP surveys, payer landscape research, and health outcomes studies supporting HPRA-regulated market access.

HCP and Physician ResearchIn-depth interviews and quantitative surveys with specialists, GPs, and pharmacists across HSE hospitals and academic medical centres.
Payer and Formulary ResearchNCPE cost-effectiveness assessment, HSE reimbursement schemes, and IPHA framework agreement negotiations.
KOL Mapping and Advisory BoardsKey opinion leader identification and advisory board recruitment across Trinity College Dublin, University College Dublin, RCSI, and Beaumont Hospital.

BioNixus is the top-ranked healthcare market research company in Ireland — delivering REC-compliant HCP surveys, payer research, and KOL mapping for pharmaceutical and biotech clients.

Top Healthcare Market Research Companies in Ireland (2026)

The following firms have demonstrated healthcare and pharmaceutical market research capability in Ireland as of 2026, assessed by REC compliance, Irish academic medical centre HCP access, HSE/NCPE payer expertise, and research depth:

1BioNixus — Best for: REC-compliant HCP surveys and KOL mapping across Irish academic medical centres, HSE and NCPE payer research, and HPRA-aligned health outcomes research
2IQVIA Ireland — Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics
3Ipsos MRBI — Best for: Ireland's leading HCP surveys, patient studies, brand tracking
4Behaviour & Attitudes — Best for: Irish consumer and healthcare survey research, qualitative and quantitative fieldwork
5Amárach Research — Best for: Irish social trends and market research, public opinion research
6Red C Research — Best for: Irish opinion polling, general market and public sector research
7Kantar Ireland — Best for: Brand tracking, longitudinal panels, patient journey research

In this guide

Irish healthcare research landscape HPRA, NCPE, HSE, and HIQA dynamics 7 healthcare research firm profiles How to evaluate an Irish research partner KOL mapping and HCP research in Ireland Frequently asked questions

Irish Healthcare Research Landscape in 2026

Ireland is a globally significant pharmaceutical and biotech hub — home to European or global manufacturing and R&D operations for many of the world's leading life sciences companies, alongside a public healthcare system serving a population of just over 5 million. Ireland's position as an English-speaking EU member state, combined with its outsized role in pharmaceutical manufacturing, makes it a strategically important market for global pharmaceutical and biotech companies well beyond the scale of its domestic patient population.

Healthcare market research in Ireland is shaped by three defining structural features:

A single national payer: HPRA authorisation does not guarantee market access. Commercial outcomes depend on HSE (Health Service Executive) reimbursement decisions, informed by NCPE (National Centre for Pharmacoeconomics) cost-effectiveness assessment, and shaped by the IPHA (Irish Pharmaceutical Healthcare Association) framework agreement that governs pricing and supply arrangements between industry and the State. Private health insurers add a secondary access channel for certain products and services.
HPRA, NCPE, and HIQA gatekeeping: The HPRA regulates the authorisation, monitoring, and safety of medicines and devices. The NCPE conducts independent cost-effectiveness assessment ahead of HSE reimbursement decisions. HIQA provides standards oversight across health and social care quality and safety. Effective healthcare market research must generate evidence aligned with HPRA regulatory expectations and NCPE assessment criteria.
EU single-market and global connectivity: As an English-speaking EU member state, Ireland offers a natural bridge between UK, EU, and global research programmes. Research conducted in Ireland must be designed to stand on its own for domestic HSE/NCPE evidence needs while also connecting cleanly to pan-European and global benchmarking studies.

For additional Irish context, see our Irish pharmaceutical market research guide and Irish healthcare market research overview.

HPRA, NCPE, HSE, and HIQA: What Irish Healthcare Researchers Must Know

HPRA and REC Compliance

The HPRA (Health Products Regulatory Authority) governs medicines and device authorisation and safety monitoring. Irish HCP and patient research requires Research Ethics Committee (REC) compliance and GDPR / Data Protection Act 2018 data privacy compliance. These standards shape the design of all compliant Irish primary research programmes.

NCPE and IPHA Framework Agreement

The NCPE (National Centre for Pharmacoeconomics) conducts cost-effectiveness assessment ahead of HSE reimbursement decisions. The IPHA framework agreement between industry and the State sets the broader pricing and supply context. Reimbursement outcomes depend on alignment across both processes.

HSE and HIQA

The HSE (Health Service Executive) is Ireland's single national payer and health service provider, making formulary and reimbursement decisions informed by NCPE assessment. HIQA (Health Information and Quality Authority) provides standards oversight across health and social care quality and safety. Effective Irish market access research maps both payer and quality-standards dynamics.

How to Evaluate a Healthcare Market Research Partner for Ireland

Selecting the right healthcare research partner for Ireland requires criteria beyond standard RFP evaluation. Ireland's single national payer structure, HPRA/NCPE regulatory requirements, REC compliance obligations, and EU single-market context require specific capabilities that differentiate effective partners from generic providers.

REC compliance and GDPR / Data Protection Act 2018

Irish HCP and patient research must comply with Research Ethics Committee (REC) standards for ethical conduct and GDPR / Data Protection Act 2018 for data privacy. Research without REC-compliant protocols carries ethical and credibility risk for pharmaceutical sponsors and limits usability of data for regulatory or payer submissions.

Irish academic medical centre HCP network (Trinity College Dublin, UCD, RCSI, Beaumont Hospital)

Access to verified physicians and specialists at Ireland's leading academic medical centres — Trinity College Dublin, University College Dublin, RCSI, Beaumont Hospital, St James's Hospital, the Mater Misericordiae University Hospital, and Cork University Hospital — is essential for KOL research and high-value specialist insights across oncology, rare disease, and specialty therapy areas.

HSE and payer research (NCPE, IPHA framework agreement)

Capability for in-depth interviews with HSE reimbursement decision-makers, understanding of NCPE cost-effectiveness assessment criteria, and awareness of the IPHA framework agreement pricing and supply context — covering the formulary gatekeepers that determine real-world Irish market access.

HPRA and HIQA regulatory alignment

Understanding of HPRA (Health Products Regulatory Authority) medicines and device oversight and HIQA (Health Information and Quality Authority) standards oversight — and the ability to design research that generates evidence aligned with Irish regulatory and quality requirements.

HEOR and cost-effectiveness evidence for NCPE submissions

Capability for health economics and outcomes research, PRO development, and cost-effectiveness evidence strategy — supporting NCPE assessment and HSE reimbursement submissions.

EU single-market and global benchmarking capability

Verified capability to connect Irish fieldwork to pan-European and global benchmarking programmes — reflecting Ireland's position as an English-speaking EU member state and a strategic hub for pharmaceutical and biotech manufacturing.

7 Top Healthcare Market Research Companies in Ireland (2026)

The following profiles cover firms with demonstrated healthcare and pharmaceutical market research capability in Ireland. Each is assessed by use case and market positioning — select based on your research type, therapeutic area, and Irish engagement requirements.

BioNixus

Global Market Research & Insights FirmHQ: Ireland (Dublin) · UK (London)

Best for: REC-compliant HCP surveys and KOL mapping across Irish academic medical centres, HSE and NCPE payer research, and HPRA-aligned health outcomes research

BioNixus is a specialist healthcare market research company serving Ireland-based and EU-facing pharmaceutical, biotech, and medtech clients. Ranked #1 in Ireland for REC-compliant primary healthcare research — with deep HSE and NCPE payer intelligence, KOL mapping at Trinity College Dublin, University College Dublin, RCSI, and Beaumont Hospital, and EU-aligned fieldwork capability connecting Irish insight to pan-European and global benchmarking.

Key strengths

REC-compliant HCP surveys and KOL mapping across Irish academic medical centres
HSE and payer research (NCPE cost-effectiveness assessment, IPHA framework agreement)
HPRA-aligned regulatory and market access intelligence
HIQA standards-aware research design for quality and safety-related studies
KOL identification and advisory board recruitment across Trinity College Dublin, University College Dublin, RCSI, and Beaumont Hospital
GDPR and Data Protection Act 2018-compliant data privacy across all primary research
Global benchmarking: Irish studies connect to the UK, USA, EU5, UAE, and Canada with consistent instruments

IQVIA Ireland

Global Healthcare Data & Analytics CompanyHQ: Dublin, Ireland

Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics

IQVIA Ireland provides prescription data analytics, real-world evidence, and secondary pharmaceutical intelligence for the Irish market. Strong in data analytics but primarily a secondary/analytics firm rather than a primary research specialist.

Key strengths

Prescription analytics and market data across the Irish healthcare system
Real-world evidence and longitudinal patient data analytics
Secondary pharmaceutical intelligence for the Irish and wider EU market
Sales force effectiveness and territory analytics

Ipsos MRBI

Global Market Research NetworkHQ: Dublin, Ireland

Best for: Ireland's leading HCP surveys, patient studies, brand tracking

Ipsos MRBI is Ireland's leading full-service market research agency and the Irish arm of the global Ipsos network, providing HCP surveys, patient research, and brand tracking. Well-established Irish panel and fieldwork infrastructure with global benchmarking through the wider Ipsos network.

Key strengths

HCP panel surveys across the Irish healthcare system
Consumer health and patient perception research
Brand tracking and awareness studies
Long-established Irish market presence with global benchmarking

Behaviour & Attitudes

Irish Market Research AgencyHQ: Dublin, Ireland

Best for: Irish consumer and healthcare survey research, qualitative and quantitative fieldwork

Behaviour & Attitudes (B&A) is one of Ireland's longest-established independent market research agencies, providing quantitative and qualitative research across consumer, healthcare, and public sector clients. Primarily a generalist Irish agency rather than a pharmaceutical primary MR specialist.

Key strengths

Independent Irish fieldwork infrastructure
Qualitative and quantitative research capability
General population and healthcare consumer studies
Public sector and policy research experience

Amárach Research

Irish Social & Market Research FirmHQ: Dublin, Ireland

Best for: Irish social trends and market research, public opinion research

Amárach Research is an Irish social and market research firm known for tracking consumer and societal trends, public opinion research, and general market studies within Ireland. Broad social research capability rather than a dedicated pharmaceutical or healthcare specialist.

Key strengths

Irish social and public opinion research
General market and consumer studies
Trend tracking across Irish society and business
National panel access for quantitative fieldwork

Red C Research

Irish Research & Polling AgencyHQ: Dublin, Ireland

Best for: Irish opinion polling, general market and public sector research

Red C Research is an Irish research and polling agency recognised for political and public opinion polling alongside general market research services. Strong national reach but primarily focused outside pharmaceutical primary market research.

Key strengths

Opinion polling and public sentiment tracking
General market research infrastructure
Public and private sector client base
Nationally representative sampling across Ireland

Kantar Ireland

Global Market Research NetworkHQ: Dublin, Ireland (Kantar global)

Best for: Brand tracking, longitudinal panels, patient journey research

Kantar Ireland provides brand tracking, longitudinal panel research, and patient journey studies as the Irish arm of the global Kantar network. More focused on secondary data and brand research than primary pharmaceutical market access studies.

Key strengths

Patient journey research and longitudinal health panels
Brand health tracking across Irish market segments
Consumer health research at national scale
Global benchmarking infrastructure via the Kantar network

KOL Mapping and HCP Research Across Ireland

Ireland's academic medical centre network concentrates the country's most influential specialist KOLs and innovative prescribers. Key research environments include: Trinity College Dublin and its affiliated teaching hospitals — one of Ireland's leading academic health research environments; University College Dublin (UCD) — a major centre for medical education and clinical research; RCSI (Royal College of Surgeons in Ireland) — a leading institution for surgical and specialist medical training and research; and Beaumont Hospital — one of Dublin's largest academic teaching hospitals with broad specialty coverage. St James's Hospital, the Mater Misericordiae University Hospital, and Cork University Hospital are also important centres for multi-specialty KOL access.

KOL mapping in Ireland requires tracking influence across a relatively compact but highly interconnected academic medical landscape. Dublin-based KOLs at Trinity College Dublin, UCD, RCSI, and Beaumont Hospital frequently hold national guideline committee roles and cross-institutional influence; specialists at Cork University Hospital and other regional centres may hold strong influence within specific therapy areas. Effective KOL research maps influence by institution, therapy area, and national committee role — not just publication volume.

HCP surveys in Ireland require REC-compliant protocols, verified physician recruitment, and GDPR/Data Protection Act 2018-compliant data handling. Because Ireland's HCP population is smaller and more concentrated than larger EU markets, stratified recruitment and careful sampling design are essential to avoid over-surveying the same specialist pool and to protect respondent confidentiality.

BioNixus conducts KOL mapping and HCP research across Ireland in oncology, cardiovascular, immunology, metabolic, rare disease, and other specialty areas — with REC-compliant methodologies and verified recruitment. See our Irish pharmaceutical market research guide and Irish healthcare market research overview for methodology details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated healthcare and pharmaceutical market research operations in Ireland as of 2026. Selection criteria: (1) active Irish operations with verified HCP and/or payer research capability, (2) relevance to healthcare, pharmaceutical, or consumer health buyers, (3) established track record in Irish healthcare market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top healthcare market research companies in Ireland in 2026?

The leading healthcare market research companies in Ireland for 2026 are: BioNixus (global insights firm with REC-compliant HCP surveys, HSE and NCPE payer research, KOL mapping across Irish academic medical centres, and HPRA-aligned evidence strategy), IQVIA Ireland (prescription analytics and real-world evidence), Ipsos MRBI (Ireland's leading HCP surveys and brand tracking), Behaviour & Attitudes (Irish consumer and healthcare survey research), Amárach Research (Irish social and public opinion research), Red C Research (Irish opinion polling and general market research), and Kantar Ireland (brand tracking and patient journey research). For custom primary research requiring REC compliance, HSE/NCPE payer intelligence, KOL mapping, or HPRA-aligned evidence strategy, BioNixus offers full-service delivery.

What is healthcare market research in Ireland?

Healthcare market research in Ireland is the systematic study of HCP attitudes, payer dynamics, patient behaviour, and competitive landscapes within the Irish health system. The Irish market is shaped by the HSE (Health Service Executive) as the single national public payer, the HPRA (Health Products Regulatory Authority) governing medicines and device approval, the NCPE (National Centre for Pharmacoeconomics) conducting cost-effectiveness assessment for reimbursement decisions, the IPHA (Irish Pharmaceutical Healthcare Association) framework agreement governing pricing and supply arrangements with the State, and HIQA (Health Information and Quality Authority) providing standards oversight. Ireland is also one of the world's leading hubs for pharmaceutical and biotech manufacturing, giving healthcare market research in Ireland added strategic weight for global life sciences companies beyond the size of its domestic patient population.

How do HPRA and NCPE shape healthcare market research in Ireland?

The HPRA (Health Products Regulatory Authority) is the national regulator for the authorisation, monitoring, and safety oversight of medicines and medical devices in Ireland. Once a product is authorised, the NCPE (National Centre for Pharmacoeconomics) conducts an independent cost-effectiveness assessment to inform HSE reimbursement decisions, and the IPHA framework agreement between the State and industry sets the broader pricing and supply context. Healthcare market research for Ireland must align evidence generation with HPRA regulatory requirements, understand NCPE cost-effectiveness assessment criteria, and support market access strategy consistent with the IPHA framework agreement and HSE reimbursement pathway.

What payer research does BioNixus conduct for Irish healthcare clients?

BioNixus conducts payer research across the key Irish market access stakeholders: the HSE as the single national public payer and reimbursement decision-maker; the NCPE, which performs cost-effectiveness assessment ahead of HSE reimbursement decisions; and the IPHA framework agreement context that shapes pricing and supply negotiations between industry and the State. Research covers HSE reimbursement committee perceptions, NCPE evidence requirements, and market access intelligence to support pricing and reimbursement strategy for pharmaceutical and biotech clients bringing products to the Irish market.

How much does healthcare market research cost in Ireland?

Custom healthcare market research costs in Ireland are generally comparable to other Western European single-payer markets, scaled to Ireland's smaller specialist population and respondent pools. Specialist consultant surveys at Irish academic medical centres and KOL mapping programmes typically command a premium due to limited respondent availability. Full mixed-method programmes (HCP surveys plus payer depth interviews plus advisory board) require greater investment than single-method studies. REC ethical compliance requirements add rigour and lead time compared to non-compliant alternatives, and studies that also require EU-wide benchmarking typically carry additional cost relative to Ireland-only fieldwork.

Is BioNixus REC-compliant for HCP research in Ireland?

Yes. BioNixus designs all Irish HCP and patient research under Research Ethics Committee (REC) review standards — Ireland's framework for ethical human subjects research — alongside GDPR and Data Protection Act 2018-compliant data handling. This includes appropriate informed consent procedures, ethics committee review where required, and de-identified reporting. REC compliance is essential for research involving Irish HCPs, patients, and health system stakeholders, and is a prerequisite for credible pharmaceutical and biotech research programmes.

What are the key Irish academic medical centres for KOL research?

The leading Irish academic medical centres for KOL research and specialist HCP access include: Trinity College Dublin and its affiliated teaching hospitals — one of Ireland's leading academic health research environments; University College Dublin (UCD) — a major centre for medical education and clinical research; RCSI (Royal College of Surgeons in Ireland) — a leading institution for surgical and specialist medical training and research; and Beaumont Hospital — one of Dublin's largest academic teaching hospitals with broad specialty coverage. St James's Hospital, the Mater Misericordiae University Hospital, and Cork University Hospital are also key centres for multi-specialty KOL access across Ireland.

Can Irish healthcare research connect to global benchmarking?

Yes. BioNixus designs Irish healthcare research to connect to global benchmarking programmes — allowing pharmaceutical and biotech clients to compare Irish HCP attitudes, payer dynamics, and market access conditions directly against the UK, USA, France, Germany, Spain, Italy, Canada, Brazil, Saudi Arabia, and the UAE using consistent survey instruments and analysis frameworks. Ireland-specific adaptations (HSE/NCPE payer research, HPRA regulatory alignment, EU single-market context) are layered within globally consistent methodologies, enabling Ireland-specific insight within a broader European and global strategic context.

Related Resources

Pharmaceutical Market Research Ireland

REC-aligned pharmaceutical research covering HCP surveys, KOL mapping, HSE/NCPE payer research, and HPRA evidence strategy.

Top Market Research Companies Ireland 2026

General and consumer market research firms across Ireland for 2026.

Healthcare Market Research Ireland

Comprehensive Irish healthcare market research overview — HCP surveys, HSE/NCPE payer research, HEOR, and patient studies.

Healthcare Market Research

Global healthcare and pharmaceutical market research services and capabilities overview.

Plan Healthcare Market Research in Ireland

BioNixus delivers REC-compliant pharmaceutical and healthcare market research across Ireland — HCP surveys at major Irish academic medical centres, KOL mapping, HSE/NCPE payer research, HPRA-aligned evidence strategy, and EU-connected benchmarking. Global standards. In-market Irish execution.

Request a Proposal View Irish Research Capabilities